Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Studies to address reports of human T-lymphotropic virus type I tax sequences in US blood donors.

Cowan EP, Tabor E, Nemo G, Williams A, Lal RB, Busch MP.

Transfusion. 1998 Aug;38(8):800-1. No abstract available.

PMID:
9709792
2.

Detection of human T-lymphotropic virus (HTLV) tax sequences in New York City blood donors seronegative for HTLV types 1 and 2.

Dezzutti CS, Guenthner PC, Daniel S, Utz U, Cabrera T, Marshall JH, Bianco C, Lal RB, Cowan EP.

Clin Diagn Lab Immunol. 2003 Jul;10(4):715-7.

3.
4.

Human T-cell lymphotropic virus type I (HTLV-I)-related clinical and laboratory findings for HTLV-I-infected blood donors.

Furukawa Y, Kubota R, Eiraku N, Nakagawa M, Usuku K, Izumo S, Osame M.

J Acquir Immune Defic Syndr. 2003 Mar 1;32(3):328-34.

PMID:
12626894
5.

Absence of human T-lymphotropic virus type I tax sequences in a population of normal blood donors in the Baltimore, MD/Washington, DC, area: results from a multicenter study.

Cowan EP, Nemo GJ, Williams AE, Alexander RK, Vallejo A, Hewlett IK, Lal RB, Dezzutti CS, Gallahan D, George K, Pancake BA, Zucker-Franklin D, McCurdy PR, Tabor E.

Transfusion. 1999 Aug;39(8):904-9.

PMID:
10504129
6.

Human T-cell lymphotropic virus type 1 tax among American blood donors.

Zucker-Franklin D, Pancake BA.

Clin Diagn Lab Immunol. 1998 Nov;5(6):831-5.

7.

Detection of HTLV-I and -II in Scottish blood donor samples and archive donations.

Davidson F, Lycett C, Jarvis LM, Kerr D, Lumley S, Petrik J, Dow BC.

Vox Sang. 2006 Oct;91(3):231-6.

PMID:
16958835
8.

Higher human T lymphotropic virus (HTLV) provirus load is associated with HTLV-I versus HTLV-II, with HTLV-II subtype A versus B, and with male sex and a history of blood transfusion.

Murphy EL, Lee TH, Chafets D, Nass CC, Wang B, Loughlin K, Smith D; HTLV Outcomes Study Investigators..

J Infect Dis. 2004 Aug 1;190(3):504-10. Epub 2004 Jul 6.

PMID:
15243924
9.

International forum: Saudi Arabia. Donor screening for HTLV-I in Saudi Arabia: is it cost effective?

Bernvil SS, Andrews V, Coulter N.

Transfus Sci. 1997 Mar;18(1):45-7.

PMID:
10174291
10.

HTLV Tax gene expression in patients with lymphoproliferative disorders.

Cardoso EA, Miranda N, Gameiro P, Frade MJ, Figueiredo M, Parreira A.

J Clin Pathol. 1996 Nov;49(11):938-41.

11.

Reduction of HTLV-I-infected cells in blood by leukocyte filtration.

Al EJ, Visser SC, Broersen SM, Stienstra S, Huisman JG.

Ann Hematol. 1993 Dec;67(6):295-300.

PMID:
8280813
12.

Human T-lymphotropic virus type I screening in volunteer blood donors--United States, 1989.

Centers for Disease Control (CDC)..

MMWR Morb Mortal Wkly Rep. 1990 Dec 21;39(50):915, 921-4.

PMID:
1979140
13.
14.
15.

Saudi National Guard donor screening for human T cell lymphotropic virus I/II: time to use molecular biology techniques.

Balkhy HH, Memish ZA, Abed E, Qasem L, Amer AB, Masoud S, Hajeer AH.

Mil Med. 2004 Mar;169(3):251-3.

PMID:
15080248
16.

Molecular evidence of HTLV-1 intrafamilial transmission in a non-endemic area in Argentina.

Gastaldello R, Otsuki K, Barbas MG, Vicente AC, Gallego S.

J Med Virol. 2005 Jul;76(3):386-90.

PMID:
15902707
17.

Screening blood products for HTLV-I: what is the best approach?

Vesilind GW, Koepke JA, DesHarnais GR.

Transfus Sci. 1990;11(1):103-12.

PMID:
10149525
18.

Evidence among blood donors for a 30-year-old epidemic of human T lymphotropic virus type II infection in the United States.

Murphy EL, Watanabe K, Nass CC, Ownby H, Williams A, Nemo G.

J Infect Dis. 1999 Dec;180(6):1777-83.

PMID:
10558931
19.

[Increased awareness of infections caused by the HTLV-1 virus].

Zań≠des VM.

Gematol Transfuziol. 1989 May;34(5):39-42. Review. Russian. No abstract available.

PMID:
2663625
20.

Supplemental Content

Support Center